Aon's New Vaccine Supply Chain Solution to Benefit Response Fund for the World Health Organization

Rhea-AI Summary

Aon plc (NYSE: AON) has announced that it will donate 100% of its 2021 revenues from its new vaccine supply chain solution to the COVID-19 Solidarity Response Fund, committing a minimum of $100,000. This solution aims to enhance the distribution of COVID-19 vaccines by offering transparent cargo insurance and leveraging sensor data for maintaining temperature control during transport. The COVID-19 Solidarity Response Fund has distributed over $250 million to support WHO's efforts in combating the pandemic, including reducing transmission and mortality, and ensuring equitable access to vaccines.

Positive

• Aon's new vaccine supply chain solution supports global vaccine distribution, enhancing company reputation.
• The commitment to donate 100% of revenues demonstrates corporate social responsibility.

Negative

• None.

CHICAGO, May 25, 2021 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional services firm providing a broad range of risk, retirement and health solutions, has announced it will donate 100 percent of all 2021 revenues earned from its new vaccine supply chain solution to the COVID-19 Solidarity Response Fund, powered by the WHO Foundation and the United Nations Foundation in support of the World Health Organization (WHO). Aon commits to donating a minimum of $100,000.

Delivered through broad industry collaboration, Aon's recently launched solution provides supply chain protection for global COVID-19 vaccine shipments and is designed to help maximize the number of doses that are administered to the public. The solution provides transparent cargo insurance coverage for COVID-19 vaccines and combines sensor data and analytics to deliver timely payment for doses that fall outside of the agreed-upon temperature range while being transported or stored. Qualified parties in the vaccine supply chain are eligible, including pharmaceutical firms, government bodies, transportation and logistics companies, distributors, health systems, pharmacy chains and inoculation centers.

"As we continue to move toward the 'New Better' and have seen incredible progress in some areas when it comes to vaccine distribution, the COVID-19 pandemic is still affecting communities around the world in unprecedented ways and its impact will continue to reverberate for years to come," said Greg Case, CEO, Aon. "By benefitting the COVID-19 Solidarity Response Fund, our new collaborative solution is not only providing first-hand support in supply chain management, but also aiding other critical life-saving efforts of the WHO Foundation."

The COVID-19 Solidarity Response Fund for the WHO is the only way for individuals, corporations, foundations and other organizations around the world to directly support the work of the WHO and its partners to help countries prevent, detect and respond to the COVID-19 pandemic. As of May 2021, the fund has put more than $250 million in donations to work. Donations support the WHO's efforts including suppressing worldwide transmission of the virus, reducing mortality, protecting the vulnerable and accelerating equitable access to new COVID-19 tools.

"Navigating vaccine distribution at a global scale is one of the most immediate and pressing hurdles facing our leaders today," said Paul Kim, Head of Strategy and Product Development, Commercial Risk Solutions at Aon. "It is an honor to support the WHO Foundation to maximize the impact of our efforts. We are proud to not only provide an innovative offering to help work toward equitable global distribution, but to also directly benefit a fund that is impacting communities around the world in the fight against COVID-19."

Learn more about how businesses have shifted in response to the COVID-19 pandemic in Helping Organizations Chart a Course to The New Better.

About Aon
Aon plc (NYSE: AON) is a leading global professional services firm providing a broad range of risk, retirement and health solutions. Our 50,000 colleagues in 120 countries empower results for clients by using proprietary data and analytics to deliver insights that reduce volatility and improve performance.

Follow Aon on Twitter and LinkedIn
Stay up to date by visiting the Aon Newsroom and hear from Aon's expert advisors in The One Brief.
Sign up for News Alerts here

Aon UK Limited is authorised and regulated by the Financial Conduct Authority for the provision of regulated products and services in the UK. Registered in England and Wales. Registered number: 00210725. Registered Office: The Aon Centre, The Leadenhall Building, 122 Leadenhall Street, London EC3V 4AN. [FP.GBC.381.JJ]. 

Media Contact
Nadine Youssef
mediainquiries@aon.com
Toll-free (U.S., Canada and Puerto Rico): +1 833 751 8114
International: +1 312 381 3024

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/aons-new-vaccine-supply-chain-solution-to-benefit-response-fund-for-the-world-health-organization-301298052.html

SOURCE Aon plc

FAQ

What is Aon's commitment regarding its new vaccine supply chain solution?

Aon has committed to donate 100% of its 2021 revenues from its new vaccine supply chain solution to the COVID-19 Solidarity Response Fund, with a minimum contribution of $100,000.

How does Aon's vaccine supply chain solution benefit global vaccine distribution?

The solution offers transparent cargo insurance and uses sensor data to ensure vaccines remain within required temperature ranges during transport.

What is the COVID-19 Solidarity Response Fund?

The COVID-19 Solidarity Response Fund supports WHO's efforts in preventing and responding to the COVID-19 pandemic and has distributed over $250 million for various initiatives.

When was the press release regarding Aon's vaccine supply chain solution published?

The press release was published on May 25, 2021.

What is the impact of Aon’s donation on its business reputation?

Aon's donation commitment enhances its corporate social responsibility profile and can positively influence its reputation in the market.